Vaxart Inc. Logo

Vaxart Inc. (VXRT)

OTC

Currency in USD
0.4100
-0.03 (-6.82%)

Closed

Oct 23, 2026

Day's Range

0.4100
0.4500

52 wk Range

0.3100
0.8400

Overview - VXRT - Vaxart Inc.

Key Statistics

Valuation

Enterprise Value

58.49M

P/E (Trailing)

‪2.64‬

P/E (Forward)

‪-0.43‬

PEG Ratio

‪-0.18‬

Price / Sales (TTM)

‪0.45‬

Price / Book

‪1.32‬

EV / EBITDA

‪1.28‬

Profitability

Profit Margin

‪15.87%‬

Operating Margin

‪-48.45%‬

Return on Assets

‪15.03%‬

Return on Equity

‪66.96%‬

Ownership

Shares Outstanding

242.83M

Float

239.24M

Short % of Shares Outstanding

‪7.51%‬

Held by Insiders

‪1.42%‬

Held by Institutions

‪0.05%‬

Price stats

Beta

‪1.05‬

50-Day Avg

‪0.4854‬

200-Day Avg

‪0.5906‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

3 analysts

Average price target

‪$ 3.33‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Latest News - VXRT - Vaxart Inc.

News & Analysis

View all news

Market Cap - VXRT - Vaxart Inc.

Peers - VXRT - Vaxart Inc.

Profile Summary - VXRT - Vaxart Inc.

About

Vaxart Inc. is a biotechnology company specializing in the development of oral recombinant vaccines. Its primary function is to create vaccine candidates that can be administered in tablet form, offering a painless and potentially more accessible alternative to traditional injectable vaccines. This innovation is…

SectorHealthcare
IndustryBiotechnology
Employees65
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.